Advanced BioDesign

Advanced BioDesign is a biotechnology company focused on developing innovative therapies for cancer. With a commitment to addressing high unmet medical needs, Advanced BioDesign has pioneered a therapeutic approach centered on the selective inhibition of ALDH enzymes. This groundbreaking strategy aims to block the intracellular mechanisms of detoxification that cancer cells develop to evade apoptosis, offering a promising new avenue for cancer treatment.

Operating from its primary location at Parc Technologique de Lyon, 655 allée des Parcs, Bâtiment D, Saint-Priest, Rhône-Alpes 69800, FR, Advanced BioDesign is dedicated to advancing its small-molecule inhibitors through clinical stages. The company's focus on oncology and its expertise in ALDH enzyme inhibition positions it as a key player in the fight against cancer.

Advanced BioDesign is poised for continued growth and commercial development in the biotechnology sector. The company's innovative approach and dedication to overcoming tumor drug resistance make it an exciting prospect for future advancements in cancer therapy. To further enhance your company's visibility, we invite the management team at Advanced BioDesign to create a customized and exclusive company showcase and product listing on our platform.